Literature DB >> 3969435

Metyrapone for depression and delirium secondary to Cushing's syndrome.

K G Kramlinger, G C Peterson, P K Watson, L L Leonard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3969435     DOI： 10.1016/S0033-3182(85)72906-4

Source DB:  PubMed          Journal:  Psychosomatics        ISSN： 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  6 in total

Review 1.  Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment.

Authors:  N Sonino; G A Fava
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential.

Authors:  L H Price; R T Malison; C J McDougle; G H Pelton
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

Review 3.  Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.

Authors:  B Dubrovsky
Journal:  J Psychiatry Neurosci       Date:  1993-01       Impact factor: 6.186

4.  Dexamethasone target sites in the central nervous system and their potential relevance to mental illness.

Authors:  M K Birmingham; M Sar; W E Stumpf
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

5.  Effects of adrenocortical steroids on long-term potentiation in the limbic system: basic mechanisms and behavioral consequences.

Authors:  B Dubrovsky; K Gijsbers; D Filipini; M K Birmingham
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

Review 6.  Neuropsychiatric disorders in Cushing's syndrome.

Authors:  Rosario Pivonello; Chiara Simeoli; Maria Cristina De Martino; Alessia Cozzolino; Monica De Leo; Davide Iacuaniello; Claudia Pivonello; Mariarosaria Negri; Maria Teresa Pellecchia; Felice Iasevoli; Annamaria Colao
Journal:  Front Neurosci       Date:  2015-04-20       Impact factor: 4.677
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.